OS Therapies Incorporated (OSTX)
ASE · Healthcare · Biotechnology
$1.70
-0.58%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$75.7M
Shares Outstanding
44.5M
Exchange
ASE
Currency
USD
About OS Therapies Incorporated
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.